{"id":"https://openalex.org/A5134317852","orcid":"https://orcid.org/0000-0002-9818-7197","observed_orcids":["https://orcid.org/0000-0002-9818-7197"],"display_name":"Maryelle A. G. de Carvalho","raw_author_names":["Maryelle A. G. de Carvalho"],"full_name":"Maryelle A. G. de Carvalho","works_count":3,"cited_by_count":7,"summary_stats":{"2yr_mean_citedness":1.5,"h_index":2,"i10_index":0},"ids":{"openalex":"https://openalex.org/A5134317852","orcid":"https://orcid.org/0000-0002-9818-7197","observed_orcids":["https://orcid.org/0000-0002-9818-7197"]},"affiliations":[{"institution":{"id":"https://openalex.org/I4104125","ror":"https://ror.org/041akq887","display_name":"Universidade Federal de Santa Catarina","country_code":"BR","type":"education","lineage":["https://openalex.org/I4104125"]},"years":[2026,2024,2023]}],"last_known_institutions":[{"id":"https://openalex.org/I4104125","ror":"https://ror.org/041akq887","display_name":"Universidade Federal de Santa Catarina","country_code":"BR","type":"education","lineage":["https://openalex.org/I4104125"]}],"topics":[{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","count":2,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","count":2,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","count":2,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10354","display_name":"Catalytic C\u2013H Functionalization Methods","count":1,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","count":1,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"topic_share":[{"id":"https://openalex.org/T10354","display_name":"Catalytic C\u2013H Functionalization Methods","value":8.5e-06,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","value":8.1e-06,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","value":6e-06,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","value":5.6e-06,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","value":4.9e-06,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"x_concepts":[{"id":"185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","score":0.8026999831199646},{"id":"71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","score":0.6233471035957336},{"id":"41685203","wikidata":"https://www.wikidata.org/wiki/Q1974042","display_name":"Docking (animal)","score":0.6069608330726624},{"id":"181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","score":0.48489999771118164},{"id":"159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","score":0.0}],"counts_by_year":[{"year":2023,"works_count":1,"oa_works_count":0,"cited_by_count":1},{"year":2024,"works_count":1,"oa_works_count":0,"cited_by_count":1},{"year":2025,"works_count":0,"oa_works_count":0,"cited_by_count":3},{"year":2026,"works_count":1,"oa_works_count":1,"cited_by_count":2}],"display_name_alternatives":["Maryelle A. G. de Carvalho"],"block_key":"m carvalho","works_api_url":"https://api.openalex.org/works?filter=author.id:A5134317852","awards_count":0,"updated_date":"2026-11-04T11:47:51","created_date":"2023-06-01T00:00:00"}
